Your browser doesn't support javascript.
loading
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
Battin, Claire; De Sousa Linhares, Annika; Leitner, Judith; Grossmann, Anna; Lupinek, Daniela; Izadi, Shiva; Castilho, Alexandra; Waidhofer-Söllner, Petra; Grabmeier-Pfistershammer, Katharina; Stritzker, Jochen; Steinberger, Peter.
Afiliación
  • Battin C; Themis Bioscience GmbH, Vienna, Austria; a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
  • De Sousa Linhares A; Loop Lab Bio GmbH, Vienna, Austria.
  • Leitner J; Themis Bioscience GmbH, Vienna, Austria; a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
  • Grossmann A; Loop Lab Bio GmbH, Vienna, Austria.
  • Lupinek D; Division of Immune Receptors and T Cell Activation, Center for Pathophysiology, Infectiology, Institute of Immunology, Medical University of Vienna, Vienna, Austria.
  • Izadi S; Themis Bioscience GmbH, Vienna, Austria; a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
  • Castilho A; Loop Lab Bio GmbH, Vienna, Austria.
  • Waidhofer-Söllner P; Themis Bioscience GmbH, Vienna, Austria; a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
  • Grabmeier-Pfistershammer K; Loop Lab Bio GmbH, Vienna, Austria.
  • Stritzker J; Department of Applied Genetics and Cell Biology, Institute for Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria.
  • Steinberger P; Department of Applied Genetics and Cell Biology, Institute for Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Austria.
Cancer Immunol Immunother ; 72(9): 3029-3043, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37310433

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Ligando 4-1BB Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Ligando 4-1BB Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos